It can take years for prostate cancer to turn castration-resistant, when cancer cells stop responding to hormonal therapy.

According to the results of the early study, published simultaneously in the New England Journal of Medicine, 92% of patients ...

Researchers at Karolinska Institutet have uncovered a unique ability of a special subtype of natural killer cells in the ...

The poster will be available on SELLAS websites following the session.

Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced it ...

Brain metastasis is emerging as the most serious concern for breast cancer patients. HER2-positive breast cancer is more prone to undergo brain metastasis than other subtypes; notably, there has been ...

Despite advancements in melanoma therapy, the prognosis remains unfavorable for many patients. The proteasome inhibitor MG132 has shown therapeutic potential through pathway regulation, yet its ...

The risk of developing blood cancer increases with age. The finding that a molecule from gut bacteria plays a part points to ...

Stanford Medicine researchers have developed a blood test capable of detecting cancers, the ways cancer resists treatments ...

Michael Wolff was at the "edge of a cliff" when he was diagnosed with a cancer that affects less than 300 patients a year in ...

According to a new study published in BMC Cancer, “CBD demonstrated significant anticancer effects, including induction of ...